Omeros Corporation Reports Second Quarter 2026 Financial Results
Omeros reported a major commercial inflection in the second quarter, with YARTEMLEA gross revenue surging 190% quarter-over-quarter to $32.2 million and net revenue reaching $28.5 million. The company utilized its operating cash flow to significantly de-risk the balance sheet, repurchasing $30.5 million in principal of its 2029 convertible notes for $60.2 million and buying back 0.5 million shares of common stock. Regulatory headlines were mixed, as the CHMP adopted a negative opinion for YARTEMLEA in Europe pending re-examination, while U.S.
Key figures
- Eps
- 0.18
- Revenue
- 28500000
- Non gaap eps
- 0.02
- Gross revenue
- 32200000
- Net cash from ops
- 4100000
- Revenue qoq growth
- 190%
- Cash and investments
- 132000000
- Notes repurchase price
- 60200000
- Share repurchase avg price
- 11.7
- Notes repurchased principal
- 30500000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.